[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:merkel-cell-carcinoma:braf-gene":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Merkel Cell Carcinoma","BRAF Gene",3,[8,16,22],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05076760","MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors",[12],"Phase 1","RECRUITING","2026-08-26T02:19:07.104270Z","2026-05-05T02:43:28.200826Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT05859074","A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer",[12],"2026-08-26T02:16:32.589113Z","2026-05-05T02:43:27.807952Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT05269381","Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors",[26],"Phase 1\u002FPhase 2","2026-08-26T02:19:10.436356Z","2026-04-29T02:57:57.121665Z"]